Mandy Boer

845 total citations
10 papers, 471 citations indexed

About

Mandy Boer is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mandy Boer has authored 10 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Mandy Boer's work include Glycosylation and Glycoproteins Research (2 papers), Cancer Cells and Metastasis (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Mandy Boer is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), Cancer Cells and Metastasis (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Mandy Boer collaborates with scholars based in Netherlands and United Kingdom. Mandy Boer's co-authors include John Hilkens, Jos Jonkers, Vassiliki Theodorou, Lodewyk F.A. Wessels, Wendy Theelen, Elvira R. M. Bakker, Ingrid C. Gaemers, Britta Weigelt, Martin van der Valk and Janet Storm and has published in prestigious journals such as Nature Communications, Nature Genetics and PLoS ONE.

In The Last Decade

Mandy Boer

10 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mandy Boer Netherlands	9	338	173	80	76	74	10	471
Ashleen Shadeo Canada	11	399 1.2×	158 0.9×	76 0.9×	162 2.1×	82 1.1×	13	584
Terry Hurst Australia	11	276 0.8×	157 0.9×	76 0.9×	63 0.8×	57 0.8×	18	477
Sanne R. Martens‐de Kemp Netherlands	13	337 1.0×	227 1.3×	76 0.9×	167 2.2×	85 1.1×	18	578
M Kashiwaba Japan	8	319 0.9×	246 1.4×	79 1.0×	147 1.9×	60 0.8×	19	566
Lisa Ursule France	6	228 0.7×	155 0.9×	68 0.8×	146 1.9×	103 1.4×	6	405
Guido Hennig Germany	9	333 1.0×	187 1.1×	36 0.5×	137 1.8×	53 0.7×	10	504
Zhongliang Ma China	10	205 0.6×	129 0.7×	66 0.8×	98 1.3×	109 1.5×	16	348
Sander P.J. Joosten Netherlands	10	288 0.9×	236 1.4×	51 0.6×	101 1.3×	55 0.7×	12	481
Sabine Franke Germany	11	281 0.8×	139 0.8×	100 1.3×	146 1.9×	150 2.0×	24	557
A P Kyritsis United States	9	269 0.8×	160 0.9×	54 0.7×	96 1.3×	39 0.5×	11	394

Countries citing papers authored by Mandy Boer

Since Specialization

Citations

This map shows the geographic impact of Mandy Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy Boer more than expected).

Fields of papers citing papers by Mandy Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy Boer. The network helps show where Mandy Boer may publish in the future.

Co-authorship network of co-authors of Mandy Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy Boer. A scholar is included among the top collaborators of Mandy Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy Boer. Mandy Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Boer, Mandy, Carola M. E. Ammerlaan, Ji‐Ying Song, et al.. (2022). R‐spondin‐3 is an oncogenic driver of poorly differentiated invasive breast cancer. The Journal of Pathology. 258(3). 289–299. 6 indexed citations

Boer, Mandy, Elvira R. M. Bakker, Jelle ten Hoeve, et al.. (2018). Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance. Oncogene. 37(12). 1594–1609. 8 indexed citations

Boer, Mandy, et al.. (2016). IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation. Nature Communications. 7(1). 13567–13567. 51 indexed citations

Hilkens, John, Mandy Boer, Matthias Schewe, et al.. (2016). RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis. Gut. 66(6). 1095–1105. 52 indexed citations

Klijn, Christiaan, Marco J. Koudijs, Jaap Kool, et al.. (2013). Analysis of Tumor Heterogeneity and Cancer Gene Networks Using Deep Sequencing of MMTV-Induced Mouse Mammary Tumors. PLoS ONE. 8(5). e62113–e62113. 18 indexed citations

Theodorou, Vassiliki, Mandy Boer, Lodewyk F.A. Wessels, et al.. (2007). MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nature Genetics. 39(6). 759–769. 143 indexed citations

Theodorou, Vassiliki, Mandy Boer, Britta Weigelt, et al.. (2004). Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene. 23(36). 6047–6055. 53 indexed citations

Boer, Mandy, et al.. (2001). Cloning of novel mammary tumor progression and metastasis genes. Breast Cancer Research. 3(S1). 36–8. 58 indexed citations

Hilkens, John & Mandy Boer. (1998). Monoclonal Antibodies against the Nonmucin Domain of MUC1/Episialin. Tumor Biology. 19(Suppl. 1). 67–70. 12 indexed citations

10.

Hilkens, John, Hans L. Vos, Jelle Wesseling, et al.. (1995). Is episialin/MUC1 involved in breast cancer progression?. Cancer Letters. 90(1). 27–33. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact